A pharmacist holds a vial of lenacapavir, the new HIV prevention injectable drug. Nardus Engelbrecht …
Tag:
hiv
-
-
Key Takeaways Raymond James analysts upgraded Gilead Sciences stock to “outperform” from “market perform.” The …
-
Key Takeaways A Phase 3 trial of Gilead’s injectable drug lenacapavir found it was 100% …